Clinical Trial Update: A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluated the safety and efficacy of alefacept in de novo kidney transplant recipients; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure
• Kidney Transplantation

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: Northwestern University | Conditions: Transplant; Failure, Kidney | Phase 1 | Status: TERMINATED